There is a huge amount of doubt at the moment about FDA approval, will there be non dilutive funding or a CR at a big discount.
If all of those doubts are dismissed I have no doubt there will be a positive rerate.
We live in hope
- Forums
- ASX - By Stock
- PAR
- OARSI 2024
OARSI 2024, page-93
Featured News
Add PAR (ASX) to my watchlist
(20min delay)
|
|||||
Last
25.5¢ |
Change
-0.010(3.77%) |
Mkt cap ! $89.19M |
Open | High | Low | Value | Volume |
27.0¢ | 27.0¢ | 25.5¢ | $162.7K | 620.9K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 25008 | 25.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
26.0¢ | 34768 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 25008 | 0.255 |
8 | 215150 | 0.250 |
6 | 109763 | 0.245 |
7 | 91034 | 0.240 |
2 | 54200 | 0.235 |
Price($) | Vol. | No. |
---|---|---|
0.260 | 34768 | 1 |
0.270 | 500 | 1 |
0.275 | 6347 | 2 |
0.290 | 14580 | 3 |
0.295 | 10000 | 2 |
Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
Featured News
NVA
Nova locks in NASDAQ US market listing at a value of only US$3.3M as ASX gets quieter and quieter
MND
Monadelphous inks $200M contract with Woodside to help build Pluto LNG – but will it make Scarborough cheaper?
PAR (ASX) Chart |